Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk
Brief Summary:
RATIONALE: Cyproheptadine hydrochloride may prevent weight loss caused by cancer or cancer treatment. It is not yet known whether cyproheptadine is more effective than a placebo in preventing weight loss in young patients receiving chemotherapy for cancer.
PURPOSE: This randomized phase III trial is studying cyproheptadine hydrochloride to see how well it works in preventing weight loss in young patients receiving chemotherapy for cancer.